JP2023509189A5 - - Google Patents
Info
- Publication number
- JP2023509189A5 JP2023509189A5 JP2022541989A JP2022541989A JP2023509189A5 JP 2023509189 A5 JP2023509189 A5 JP 2023509189A5 JP 2022541989 A JP2022541989 A JP 2022541989A JP 2022541989 A JP2022541989 A JP 2022541989A JP 2023509189 A5 JP2023509189 A5 JP 2023509189A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- composition
- use according
- rspo1
- spondin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025182517A JP2026021430A (ja) | 2020-01-10 | 2025-10-29 | Ｒｓｐｏ１タンパク質およびその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20305016 | 2020-01-10 | ||
| EP20305016.6 | 2020-01-10 | ||
| PCT/EP2021/050289 WO2021140209A1 (en) | 2020-01-10 | 2021-01-08 | Rspo1 proteins and their use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025182517A Division JP2026021430A (ja) | 2020-01-10 | 2025-10-29 | Ｒｓｐｏ１タンパク質およびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023509189A JP2023509189A (ja) | 2023-03-07 |
| JP2023509189A5 true JP2023509189A5 (https=) | 2023-12-07 |
| JP7767289B2 JP7767289B2 (ja) | 2025-11-11 |
Family
ID=69185555
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022541989A Active JP7767289B2 (ja) | 2020-01-10 | 2021-01-08 | Ｒｓｐｏ１タンパク質およびその使用 |
| JP2025182517A Pending JP2026021430A (ja) | 2020-01-10 | 2025-10-29 | Ｒｓｐｏ１タンパク質およびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025182517A Pending JP2026021430A (ja) | 2020-01-10 | 2025-10-29 | Ｒｓｐｏ１タンパク質およびその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230241161A1 (https=) |
| EP (1) | EP4087863A1 (https=) |
| JP (2) | JP7767289B2 (https=) |
| KR (1) | KR20220152202A (https=) |
| CN (1) | CN114929731A (https=) |
| AU (1) | AU2021205639A1 (https=) |
| BR (1) | BR112022013468A2 (https=) |
| CA (1) | CA3163861A1 (https=) |
| IL (1) | IL294571A (https=) |
| WO (1) | WO2021140209A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120813594A (zh) * | 2023-01-19 | 2025-10-17 | 迪奥根克斯公司 | R-spondin蛋白的重组变体及其用途 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4634665A (en) | 1980-02-25 | 1987-01-06 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US5179017A (en) | 1980-02-25 | 1993-01-12 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4751180A (en) | 1985-03-28 | 1988-06-14 | Chiron Corporation | Expression using fused genes providing for protein product |
| US4935233A (en) | 1985-12-02 | 1990-06-19 | G. D. Searle And Company | Covalently linked polypeptide cell modulators |
| GB8725529D0 (en) | 1987-10-30 | 1987-12-02 | Delta Biotechnology Ltd | Polypeptides |
| SE509359C2 (sv) | 1989-08-01 | 1999-01-18 | Cemu Bioteknik Ab | Användning av stabiliserade protein- eller peptidkonjugat för framställning av ett läkemedel |
| WO2008046649A1 (en) | 2006-10-20 | 2008-04-24 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Rspondins as modulators of angiogenesis and vasculogenesis |
| WO2008088524A2 (en) * | 2006-12-28 | 2008-07-24 | Nuvelo, Inc. | Thrombospondin-domain-deficient r-spondin 1 protein as gastrointestinal tract epithelial proliferation factor |
| WO2013054307A2 (en) * | 2011-10-14 | 2013-04-18 | Novartis Ag | Antibodies and methods for wnt pathway-related diseases |
| WO2014059068A1 (en) * | 2012-10-11 | 2014-04-17 | The Trustees Of The University Of Pennsylvania | Methods for the treatment and prevention of osteoporosis and bone-related disorders |
| WO2016193497A1 (en) * | 2015-06-04 | 2016-12-08 | Ospedale San Raffaele Srl | Inhibitor of igfbp3/tmem219 axis and diabetes |
| JP2021020900A (ja) | 2019-07-29 | 2021-02-18 | 国立大学法人北海道大学 | 糖代謝異常改善剤 |
| IL310154A (en) * | 2021-07-15 | 2024-03-01 | Diogenx | Recombinant variants of r-spondin proteins and their use |
-
2021
- 2021-01-08 US US17/758,540 patent/US20230241161A1/en active Pending
- 2021-01-08 IL IL294571A patent/IL294571A/en unknown
- 2021-01-08 JP JP2022541989A patent/JP7767289B2/ja active Active
- 2021-01-08 EP EP21700006.6A patent/EP4087863A1/en active Pending
- 2021-01-08 WO PCT/EP2021/050289 patent/WO2021140209A1/en not_active Ceased
- 2021-01-08 CN CN202180008384.XA patent/CN114929731A/zh active Pending
- 2021-01-08 BR BR112022013468A patent/BR112022013468A2/pt unknown
- 2021-01-08 AU AU2021205639A patent/AU2021205639A1/en active Pending
- 2021-01-08 KR KR1020227027675A patent/KR20220152202A/ko active Pending
- 2021-01-08 CA CA3163861A patent/CA3163861A1/en active Pending
-
2025
- 2025-10-29 JP JP2025182517A patent/JP2026021430A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6412183B2 (ja) | 作用持続時間が増した改変ポリペプチド | |
| US11858975B2 (en) | Multi-domain active protein for treating metabolic diseases | |
| JP6618854B2 (ja) | 作用持続期間が増大し、免疫原性が減少した操作されたポリペプチド | |
| JP6229038B2 (ja) | 修飾された血管作動性腸管ペプチド | |
| KR100879662B1 (ko) | Ｇｌｐ-1 유사체 융합 단백질 제제 | |
| CN102625811B (zh) | Fgf21突变体及其用途 | |
| JP2017529059A5 (https=) | ||
| CN108350054A (zh) | 双功能蛋白质和包含其的药物组合物 | |
| KR20170049319A (ko) | 지속형 fgf21 융합 단백질 및 이를 포함하는 약학적 조성물 | |
| JP7174149B2 (ja) | ＧＬＰ１－Ｆｃ融合タンパク質及びその複合体 | |
| JP2016512213A5 (https=) | ||
| JP2022523972A (ja) | 増殖分化因子１５併用療法 | |
| CN114591415B (zh) | Glp-1/gcg双受体激动剂多肽及其融合蛋白 | |
| CA3000697A1 (en) | Treatment of bile acid disorders | |
| WO2018077098A1 (zh) | 一种用于治疗肠道疾病的融合蛋白 | |
| CN106279430A (zh) | Exendin-4类似物融合蛋白及其制备方法和用途 | |
| JP2023509189A5 (https=) | ||
| CN118076373A (zh) | 用于联合疗法的包括生长分化因子-15变体和胰高血糖素样肽-1受体激动剂的组合物 | |
| JP2025509520A5 (https=) | ||
| WO2005058358B1 (en) | Use of agents derived from ceacam1 for the treatment of inflammatory diseases | |
| CN109195983B (zh) | 胰岛新生多肽和类似物的缀合物及其方法 | |
| RU2021136703A (ru) | Новый модифицированный слитый белок fc-фрагмента иммуноглобулина и его применение | |
| JP2024537239A (ja) | インターロイキン－１０ムテイン及びその融合タンパク質 | |
| CN118620086A (zh) | 一种治疗糖尿病的融合蛋白及其应用 | |
| HK40091844A (zh) | 双功能蛋白质和包含其的药物组合物 |